Wave Life Sciences Stock Analysis

WVE Stock  USD 14.89  0.62  4.34%   
Wave Life Sciences is overvalued with Real Value of 12.7 and Target Price of 7.69. The main objective of Wave Life stock analysis is to determine its intrinsic value, which is an estimate of what Wave Life Sciences is worth, separate from its market price. There are two main types of Wave Life's stock analysis: fundamental analysis and technical analysis.
The Wave Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Wave Life's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Wave Stock Analysis Notes

About 15.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 1.12. Wave Life Sciences had not issued any dividends in recent years. Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company was incorporated in 2012 and is based in Singapore. Wave Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people. For more information please call MBA MD at 65 6236 3388 or visit https://www.wavelifesciences.com.

Wave Life Sciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Wave Life's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Wave Life Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Wave Life Sciences is way too risky over 90 days horizon
Wave Life Sciences appears to be risky and price may revert if volatility continues
The company reported the last year's revenue of 113.31 M. Reported Net Loss for the year was (57.51 M) with loss before taxes, overhead, and interest of (73.64 M).
Wave Life Sciences has about 148.16 M in cash with (19.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71.
Wave Life Sciences has a poor financial position based on the latest SEC disclosures
Over 78.0% of the company outstanding shares are owned by institutional investors
Latest headline from finance.yahoo.com: Outdoor Power Equipment Market to Propel Growth at USD 76.61 Billion by 2031 SkyQuest Technology

Wave Life Sciences Upcoming and Recent Events

27th of March 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Wave Largest EPS Surprises

Earnings surprises can significantly impact Wave Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-09
2024-03-31-0.21-0.24-0.0314 
2024-08-08
2024-06-30-0.21-0.25-0.0419 
2023-03-22
2022-12-31-0.41-0.47-0.0614 
View All Earnings Estimates

Wave Life Environmental, Social, and Governance (ESG) Scores

Wave Life's ESG score is a quantitative measure that evaluates Wave Life's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Wave Life's operations that may have significant financial implications and affect Wave Life's stock price as well as guide investors towards more socially responsible investments.

Wave Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Primecap Management Company2024-09-30
2.6 M
Geode Capital Management, Llc2024-09-30
2.3 M
State Street Corp2024-06-30
2.3 M
Emerald Mutual Fund Advisers Trust2024-09-30
2.1 M
Artisan Partners Limited Partnership2024-09-30
M
Morgan Stanley - Brokerage Accounts2024-06-30
1.7 M
Millennium Management Llc2024-06-30
1.7 M
Fmr Inc2024-09-30
1.5 M
T. Rowe Price Associates, Inc.2024-06-30
1.4 M
Ra Capital Management, Llc2024-09-30
18.2 M
Maverick Capital Ltd2024-09-30
10 M
Note, although Wave Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Wave Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 2.18 B.

Wave Profitablity

The company has Net Profit Margin of (2.66) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 8.33 %, which entails that for every 100 dollars of revenue, it generated $8.33 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.21)(0.22)
Return On Capital Employed(0.77)(0.81)
Return On Assets(0.21)(0.22)
Return On Equity(1.21)(1.27)

Management Efficiency

Wave Life Sciences has Return on Asset of (0.3404) % which means that on every $100 spent on assets, it lost $0.3404. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (2.4382) %, meaning that it generated no profit with money invested by stockholders. Wave Life's management efficiency ratios could be used to measure how well Wave Life manages its routine affairs as well as how well it operates its assets and liabilities. As of November 25, 2024, Return On Tangible Assets is expected to decline to -0.22. In addition to that, Return On Capital Employed is expected to decline to -0.81. At present, Wave Life's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 3.33, whereas Other Assets are forecasted to decline to about 4.1 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.45  0.43 
Tangible Book Value Per Share 0.45  0.43 
Enterprise Value Over EBITDA(6.25)(6.56)
Price Book Value Ratio 11.28  16.29 
Enterprise Value Multiple(6.25)(6.56)
Price Fair Value 11.28  16.29 
Enterprise Value422.7 M414.9 M
The leadership approach at Wave Life's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Operating Margin
8.3266
Profit Margin
(2.66)
Beta
(1.21)
Return On Assets
(0.34)
Return On Equity
(2.44)

Technical Drivers

As of the 25th of November, Wave Life maintains the Mean Deviation of 5.8, market risk adjusted performance of 0.5704, and Downside Deviation of 3.96. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Wave Life Sciences, as well as the relationship between them. Please check out Wave Life Sciences coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Wave Life Sciences is priced fairly, providing market reflects its latest price of 14.89 per share. Given that Wave Life Sciences has jensen alpha of 1.55, we strongly advise you to confirm Wave Life Sciences's prevalent market performance to make sure the company can sustain itself at a future point.

Wave Life Sciences Price Movement Analysis

Execute Study
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Wave Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Wave Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Wave Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Wave Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Wave Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Wave Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Wave Life Outstanding Bonds

Wave Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Wave Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Wave bonds can be classified according to their maturity, which is the date when Wave Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Wave Life Predictive Daily Indicators

Wave Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Wave Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Wave Life Corporate Filings

8K
20th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
15th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
13th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
ASR
12th of November 2024
Automatic Shelf Registration Statement under Rule 415 filed with the U.S. Securities and Exchange Commission (SEC)
ViewVerify
13A
8th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
8K
30th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
18th of October 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
8K
16th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Wave Life Forecast Models

Wave Life's time-series forecasting models are one of many Wave Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Wave Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Wave Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Wave Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Wave shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Wave Life. By using and applying Wave Stock analysis, traders can create a robust methodology for identifying Wave entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.51)(0.54)
Operating Profit Margin(0.60)(0.63)
Net Loss(0.51)(0.53)
Gross Profit Margin 0.92  0.96 

Current Wave Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Wave analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Wave analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
7.69Strong Buy10Odds
Wave Life Sciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Wave analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Wave stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Wave Life Sciences, talking to its executives and customers, or listening to Wave conference calls.
Wave Analyst Advice Details

Wave Stock Analysis Indicators

Wave Life Sciences stock analysis indicators help investors evaluate how Wave Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Wave Life shares will generate the highest return on investment. By understating and applying Wave Life stock analysis, traders can identify Wave Life position entry and exit signals to maximize returns.
Begin Period Cash Flow92.2 M
Common Stock Shares Outstanding106.1 M
Total Stockholder Equity47.5 M
Tax Provision-677 K
Property Plant And Equipment Net35.7 M
Cash And Short Term Investments200.4 M
Cash200.4 M
Accounts Payable12.8 M
Net Debt-168.2 M
50 Day M A11.5712
Total Current Liabilities186.4 M
Other Operating Expenses181.3 M
Non Current Assets Total39.6 M
Non Currrent Assets Other3.9 M
Stock Based Compensation9.8 M

Complementary Tools for Wave Stock analysis

When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Content Syndication
Quickly integrate customizable finance content to your own investment portal